Clinical trial
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT07030348 is registered in ClinicalTrials.gov with Do Hyun Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
- Lead sponsor
- Do Hyun Park
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 2, 2024
- Completion date
- December 31, 2026
- Enrollment
- 263 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancers, pancreatic diseases